Novel Gliclazide Electrosprayed Nano-Solid Dispersions: Physicochemical Characterization and Dissolution Evaluation

Purpose: In the current study, electrospraying was directed as a novel alternative approach to improve the physicochemical attributes of gliclazide (GLC), as a poorly water-soluble drug, by creating nanocrystalline/amorphous solid dispersions (ESSs). Methods: ESSs were formulated using Eudragit® RS...

Full description

Bibliographic Details
Main Authors: Khosro Adibkia, Solmaz Ghajar, Karim Osouli-Bostanabad, Niloufar Balaei, Shahram Emami, Mohammad Barzegar-Jalali
Format: Article
Language:English
Published: Tabriz University of Medical Sciences 2019-06-01
Series:Advanced Pharmaceutical Bulletin
Subjects:
Online Access:https://apb.tbzmed.ac.ir/PDF/apb-22801
id doaj-ce088d8811304d81a6823a63e1835446
record_format Article
spelling doaj-ce088d8811304d81a6823a63e18354462020-11-25T01:02:48ZengTabriz University of Medical Sciences Advanced Pharmaceutical Bulletin2228-58812251-73082019-06-019223124010.15171/apb.2019.026apb-22801Novel Gliclazide Electrosprayed Nano-Solid Dispersions: Physicochemical Characterization and Dissolution EvaluationKhosro Adibkia0Solmaz Ghajar1Karim Osouli-Bostanabad2Niloufar Balaei3Shahram Emami4Mohammad Barzegar-Jalali5Research Center for Pharmaceutical Nanotechnology and Faculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran.Drug Applied Research Center and Faculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran.Research Center for Pharmaceutical Nanotechnology, Tabriz University of Medical Sciences, Tabriz, Iran.Drug Applied Research Center and Faculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran.Faculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran.Pharmaceutical Analysis Research Center, Tabriz University of Medical Sciences, Tabriz, IranPurpose: In the current study, electrospraying was directed as a novel alternative approach to improve the physicochemical attributes of gliclazide (GLC), as a poorly water-soluble drug, by creating nanocrystalline/amorphous solid dispersions (ESSs). Methods: ESSs were formulated using Eudragit® RS100 and polyethylene glycol (PEG) 6000 as polymeric carriers at various drug: polymer ratios (i.e. 1:5 and 1:10) with different total solution concentrations of 10, 15, and 20% w/v. Morphological, physicochemical, and in-vitro release characteristics of the developed formulations were assessed. Furthermore, GLC dissolution behaviors from ESSs were fitted to various models in order to realize the drug release mechanism. Results: Field emission scanning electron microscopy analyses revealed that the size and morphology of the ESSs were affected by the drug: polymer ratios and solution concentrations. The polymer ratio augmentation led to increase in the particle size while the solution concentration enhancement yielded in a fiber establishment. Differential scanning calorimetry and powder X-ray diffraction investigations demonstrated that the ESSs were present in an amorphous state. Furthermore, the in vitro drug release studies depicted that the samples prepared employing PEG 6000 as carrier enhanced the dissolution rate and the model that appropriately fitted the release behavior of ESSs was Weibull model, where demonstrating a Fickian diffusion as the leading release mechanism. Fourier-transform infrared spectroscopy results showed a probability of complexation or hydrogen bonding, development between GLC and the polymers in the solid state. Conclusion: Hence the electrospraying system avails the both nanosizing and amorphization advantages, therefore, it can be efficiently applied to formulating of ESSs of BCS Class II drugs.https://apb.tbzmed.ac.ir/PDF/apb-22801Amorphous solid dispersionsEudragit® RS100ElectrosprayGliclazideIn vitro evaluationNanocrystalline
collection DOAJ
language English
format Article
sources DOAJ
author Khosro Adibkia
Solmaz Ghajar
Karim Osouli-Bostanabad
Niloufar Balaei
Shahram Emami
Mohammad Barzegar-Jalali
spellingShingle Khosro Adibkia
Solmaz Ghajar
Karim Osouli-Bostanabad
Niloufar Balaei
Shahram Emami
Mohammad Barzegar-Jalali
Novel Gliclazide Electrosprayed Nano-Solid Dispersions: Physicochemical Characterization and Dissolution Evaluation
Advanced Pharmaceutical Bulletin
Amorphous solid dispersions
Eudragit® RS100
Electrospray
Gliclazide
In vitro evaluation
Nanocrystalline
author_facet Khosro Adibkia
Solmaz Ghajar
Karim Osouli-Bostanabad
Niloufar Balaei
Shahram Emami
Mohammad Barzegar-Jalali
author_sort Khosro Adibkia
title Novel Gliclazide Electrosprayed Nano-Solid Dispersions: Physicochemical Characterization and Dissolution Evaluation
title_short Novel Gliclazide Electrosprayed Nano-Solid Dispersions: Physicochemical Characterization and Dissolution Evaluation
title_full Novel Gliclazide Electrosprayed Nano-Solid Dispersions: Physicochemical Characterization and Dissolution Evaluation
title_fullStr Novel Gliclazide Electrosprayed Nano-Solid Dispersions: Physicochemical Characterization and Dissolution Evaluation
title_full_unstemmed Novel Gliclazide Electrosprayed Nano-Solid Dispersions: Physicochemical Characterization and Dissolution Evaluation
title_sort novel gliclazide electrosprayed nano-solid dispersions: physicochemical characterization and dissolution evaluation
publisher Tabriz University of Medical Sciences
series Advanced Pharmaceutical Bulletin
issn 2228-5881
2251-7308
publishDate 2019-06-01
description Purpose: In the current study, electrospraying was directed as a novel alternative approach to improve the physicochemical attributes of gliclazide (GLC), as a poorly water-soluble drug, by creating nanocrystalline/amorphous solid dispersions (ESSs). Methods: ESSs were formulated using Eudragit® RS100 and polyethylene glycol (PEG) 6000 as polymeric carriers at various drug: polymer ratios (i.e. 1:5 and 1:10) with different total solution concentrations of 10, 15, and 20% w/v. Morphological, physicochemical, and in-vitro release characteristics of the developed formulations were assessed. Furthermore, GLC dissolution behaviors from ESSs were fitted to various models in order to realize the drug release mechanism. Results: Field emission scanning electron microscopy analyses revealed that the size and morphology of the ESSs were affected by the drug: polymer ratios and solution concentrations. The polymer ratio augmentation led to increase in the particle size while the solution concentration enhancement yielded in a fiber establishment. Differential scanning calorimetry and powder X-ray diffraction investigations demonstrated that the ESSs were present in an amorphous state. Furthermore, the in vitro drug release studies depicted that the samples prepared employing PEG 6000 as carrier enhanced the dissolution rate and the model that appropriately fitted the release behavior of ESSs was Weibull model, where demonstrating a Fickian diffusion as the leading release mechanism. Fourier-transform infrared spectroscopy results showed a probability of complexation or hydrogen bonding, development between GLC and the polymers in the solid state. Conclusion: Hence the electrospraying system avails the both nanosizing and amorphization advantages, therefore, it can be efficiently applied to formulating of ESSs of BCS Class II drugs.
topic Amorphous solid dispersions
Eudragit® RS100
Electrospray
Gliclazide
In vitro evaluation
Nanocrystalline
url https://apb.tbzmed.ac.ir/PDF/apb-22801
work_keys_str_mv AT khosroadibkia novelgliclazideelectrosprayednanosoliddispersionsphysicochemicalcharacterizationanddissolutionevaluation
AT solmazghajar novelgliclazideelectrosprayednanosoliddispersionsphysicochemicalcharacterizationanddissolutionevaluation
AT karimosoulibostanabad novelgliclazideelectrosprayednanosoliddispersionsphysicochemicalcharacterizationanddissolutionevaluation
AT niloufarbalaei novelgliclazideelectrosprayednanosoliddispersionsphysicochemicalcharacterizationanddissolutionevaluation
AT shahramemami novelgliclazideelectrosprayednanosoliddispersionsphysicochemicalcharacterizationanddissolutionevaluation
AT mohammadbarzegarjalali novelgliclazideelectrosprayednanosoliddispersionsphysicochemicalcharacterizationanddissolutionevaluation
_version_ 1725203508824637440